Correlation Between Aura Biosciences and Candel Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aura Biosciences and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aura Biosciences and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aura Biosciences and Candel Therapeutics, you can compare the effects of market volatilities on Aura Biosciences and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aura Biosciences with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aura Biosciences and Candel Therapeutics.

Diversification Opportunities for Aura Biosciences and Candel Therapeutics

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between Aura and Candel is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Aura Biosciences and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and Aura Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aura Biosciences are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of Aura Biosciences i.e., Aura Biosciences and Candel Therapeutics go up and down completely randomly.

Pair Corralation between Aura Biosciences and Candel Therapeutics

Given the investment horizon of 90 days Aura Biosciences is expected to generate 32.98 times less return on investment than Candel Therapeutics. But when comparing it to its historical volatility, Aura Biosciences is 4.19 times less risky than Candel Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Candel Therapeutics is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  112.00  in Candel Therapeutics on September 12, 2024 and sell it today you would earn a total of  686.00  from holding Candel Therapeutics or generate 612.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Aura Biosciences  vs.  Candel Therapeutics

 Performance 
       Timeline  
Aura Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aura Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Aura Biosciences is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Candel Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Candel Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite quite unsteady fundamental indicators, Candel Therapeutics disclosed solid returns over the last few months and may actually be approaching a breakup point.

Aura Biosciences and Candel Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aura Biosciences and Candel Therapeutics

The main advantage of trading using opposite Aura Biosciences and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aura Biosciences position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.
The idea behind Aura Biosciences and Candel Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges